Xeroderma Pigmentosum

Introduction

Introduction to Xeroderma Pigmentosum (XP)

Xeroderma pigmentosum (XP) is a rare autosomal recessive genetic disorder characterized by extreme sensitivity to ultraviolet (UV) radiation, leading to a high predisposition to skin cancers and ocular damage. The condition arises from defects in the nucleotide excision repair (NER) pathway, which is critical for repairing DNA damage induced by UV light. Without functional NER, mutations accumulate in skin cells, resulting in carcinogenesis and premature aging of the skin.

Biochemical Basis of XP

The biochemical foundation of XP lies in the impairment of the NER mechanism, which involves over 30 proteins working in concert to recognize, excise, and repair UV-induced DNA lesions such as cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts. Defects in any of the seven XP complementation groups (XPA-XPG) or the variant form (XPV) disrupt this process, leading to the clinical manifestations observed in patients.

Study

Nucleotide Excision Repair (NER) Pathway

The NER pathway is a highly conserved DNA repair mechanism that corrects bulky, helix-distorting lesions caused by UV radiation. It consists of two sub-pathways: global genome NER (GG-NER), which surveys the entire genome, and transcription-coupled NER (TC-NER), which repairs damage in actively transcribed genes. GG-NER is initiated by the XPC-RAD23B complex, which recognizes DNA distortions, while TC-NER is triggered by RNA polymerase II stalling at lesions.

XP Complementation Groups and Genetic Defects

XP is genetically heterogeneous, with mutations in any of seven genes (XPA-XPG) leading to distinct complementation groups. XPA and XPC are involved in damage recognition, while XPB and XPD are helicases that unwind DNA around the lesion. XPG and XPF are endonucleases that excise the damaged strand. The variant form, XPV, results from mutations in the POLH gene, encoding DNA polymerase η, which bypasses UV-induced lesions during replication.

UV-Induced DNA Damage and Mutagenesis

UV radiation primarily induces two types of DNA lesions: CPDs and 6-4 photoproducts. These lesions distort the DNA helix, blocking transcription and replication. In XP patients, the inability to repair these lesions leads to an increased mutation rate, particularly in tumor suppressor genes like TP53. This results in a 10,000-fold increased risk of skin cancer, including basal cell carcinoma, squamous cell carcinoma, and melanoma.

Clinical Manifestations and Diagnosis

Clinically, XP presents with severe sunburn after minimal sun exposure, freckling in sun-exposed areas, and the development of skin cancers before the age of 10. Ocular complications, such as photophobia, keratitis, and cataracts, are also common. Diagnosis is confirmed through genetic testing for mutations in XP-related genes or functional assays measuring DNA repair capacity in patient cells after UV exposure.

Therapeutic Approaches and Management

Management of XP focuses on strict UV protection, including protective clothing, sunscreen, and UV-blocking films on windows. Regular dermatological and ophthalmological surveillance is essential for early detection and treatment of malignancies. Experimental therapies, such as T4 endonuclease V (a bacterial DNA repair enzyme) and gene therapy, are being explored to restore NER function or enhance DNA repair capacity in XP patients.

Summary

Key Takeaways

Xeroderma pigmentosum is a rare genetic disorder caused by defects in the NER pathway, leading to extreme UV sensitivity and a high risk of skin cancers. The condition is genetically heterogeneous, with mutations in seven complementation groups (XPA-XPG) and a variant form (XPV) disrupting DNA repair. Early diagnosis and strict UV protection are critical for managing the disease and preventing malignancies.

Clinical Correlate

The clinical relevance of XP underscores the importance of DNA repair mechanisms in maintaining genomic integrity. Patients with XP serve as a model for understanding the consequences of defective DNA repair, highlighting the link between UV exposure, mutagenesis, and carcinogenesis. This knowledge informs public health strategies for skin cancer prevention and the development of targeted therapies for DNA repair-deficient disorders.

Biochemical Insights

The study of XP has provided profound insights into the molecular mechanisms of DNA repair and the role of NER in preventing UV-induced mutagenesis. Understanding the specific functions of XP proteins has advanced our knowledge of genome stability and the pathogenesis of cancer, paving the way for novel therapeutic approaches in oncology and genetic disorders.